Parnayavani swarasa as an adjuvant in the management of Sheetapitta w.s.r to Urticaria

Phase 3

Not yet recruiting

• Conditions: Urticaria, unspecified. Ayurveda Condition: KUSHTHAM,

• Registration Number: CTRI/2023/06/053565
• Lead Sponsor: SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH

Brief Summary

Study type - Randomized Active controlled clinical study, Pre and post test study, Timing - Prospective, Masking - Open label, Grouping - Double arm, Randomization - Lottery method, Group intervention method - Parallel

| | | |

| --- | --- | --- |

| FEATURES GROUP A - TRIAL GROUP GROUP B - CONTROL GROUP

| SAMPLE SIZE 15 15

| INTERVENTION 3grams *of Haridrakhandaand**12ml of ParnayavaniSwarasa,*BD 3grams*of Haridrakhanda,* BD

| ROUTE Oral Oral

| TIME OF ADMINISTRATION After food twice daily After food twice daily

| TRIAL PERIOD 14 days 14 days

| FOLLOW UP PERIOD 14thday and 20th day 14thday and 20th day

| STUDY PERIOD 20 days 20 days

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-05-29
• Study Start: 2023-06-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1.Patients showing minimum of 3 classical clinical feature of Sheetapitta.
• 2.Patients of age group between 21 to 60 years will be included irrespective of their gender, religion, marital status and socioeconomical status.
• 3.Subjects who are willing to participate in the study by giving the written consent.

Exclusion Criteria

• 1.Patients having associative symptoms like vomiting, fever and suffering from any other infections or systemic disorders.
• 2.History of angioedema and other skin disease like psoriasis, eczema.
• 3.History of anaphylaxis to medicine.
• 4.Subjects who are pregnant and lactating.
• 5.Subjects who are not willing to participate in the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decreased symptoms of Urticarial rashes	0th, 14th, 20th day

Secondary Outcome Measures

Name	Time	Method
Reduction in AEC count	0th, 14th, 20th day

Trial Locations

Locations (1)

Sri Sri Ayurveda Hospital; 🇮🇳 Rural, KARNATAKA, India

Sri Sri Ayurveda Hospital

🇮🇳Rural, KARNATAKA, India

Dr Sushmitha Bharadwaj H G

Principal investigator

9481765870

sushmitabharadwaj04@gmail.com